Ionis Pharmaceuticals (IONS) Insider Trading & Ownership $35.63 +0.04 (+0.11%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ionis Pharmaceuticals (NASDAQ:IONS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$11.97 M Get IONS Insider Trade Alerts Want to know when executives and insiders are buying or selling Ionis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IONS Insider Buying and Selling by Quarter Ad ProsperityPubThis Indicator called BOTH NVDA ralliesRarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. Ionis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/12/2024Brett P MoniaCEOSell6,630$38.05$252,271.50 11/12/2024Eric SwayzeEVPSell1,194$37.92$45,276.48 10/16/2024Eric SwayzeEVPSell53$38.31$2,030.43 8/28/2024Richard S GearyEVPSell320$49.16$15,731.20 8/5/2024Richard S GearyEVPSell2,430$48.00$116,640.00 7/16/2024Joseph Klein IIIDirectorSell12,000$50.00$600,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/3/2024Joseph Klein IIIDirectorSell6,000$42.71$256,260.00 4/16/2024Joseph BaroldiEVPSell4,006$41.60$166,649.60 2/16/2024Brett P MoniaCEOSell387$44.49$17,217.63 2/2/2024Brett P MoniaCEOSell23,501$49.37$1,160,244.37 2/2/2024Elizabeth L HougenCFOSell2,125$49.54$105,272.50 2/2/2024Eric SwayzeEVPSell1,907$49.56$94,510.92 1/31/2024Eric SwayzeEVPSell10,773$52.00$560,196.00 1/25/2024Brett P MoniaCEOSell2,285$51.75$118,248.75 1/25/2024Patrick R O'neilEVPSell6,450$51.75$333,787.50 1/17/2024Brett P MoniaCEOSell32,059$50.42$1,616,414.78 1/17/2024Elizabeth L HougenCFOSell8,683$50.42$437,796.86 1/17/2024Onaiza Cadoret-ManierEVPSell5,564$50.42$280,536.88 1/12/2024Eugene SchneiderEVPSell8,000$53.50$428,000.00 12/28/2023B Lynne ParshallDirectorSell42,525$50.19$2,134,329.75 12/26/2023B Lynne ParshallDirectorSell25,113$51.46$1,292,314.98 12/26/2023Patrick R O'neilEVPSell20,825$51.46$1,071,654.50 12/21/2023Brett P MoniaCEOSell17,500$49.29$862,575.00 (Data available from 1/1/2013 forward) IONS Insider Trading Activity - Frequently Asked Questions Who is on Ionis Pharmaceuticals's Insider Roster? The list of insiders at Ionis Pharmaceuticals includes Allene M Diaz, B Lynne Parshall, Brett P Monia, Brian Birchler, C Frank Bennett, Elizabeth L Hougen, Eric Swayze, Eugene Schneider, Joseph Baroldi, Joseph Klein III, Onaiza Cadoret-Manier, Patrick R O'neil, and Richard S Geary. Learn more on insiders at IONS. What percentage of Ionis Pharmaceuticals stock is owned by insiders? 2.71% of Ionis Pharmaceuticals stock is owned by insiders. Learn more on IONS's insider holdings. Which Ionis Pharmaceuticals insiders have been selling company stock? The following insiders have sold IONS shares in the last 24 months: Allene M Diaz ($26,969.85), B Lynne Parshall ($3,877,944.73), Brett P Monia ($8,369,110.40), Brian Birchler ($24,528.00), C Frank Bennett ($530,050.00), Elizabeth L Hougen ($956,171.97), Eric Swayze ($1,002,317.02), Eugene Schneider ($428,000.00), Joseph Baroldi ($166,649.60), Joseph Klein III ($1,185,570.00), Onaiza Cadoret-Manier ($280,536.88), Patrick R O'neil ($1,646,507.90), and Richard S Geary ($132,371.20). How much insider selling is happening at Ionis Pharmaceuticals? Insiders have sold a total of 395,126 Ionis Pharmaceuticals shares in the last 24 months for a total of $18,626,727.55 sold. Ionis Pharmaceuticals Key ExecutivesDr. Brett P. Monia Ph.D. (Age 63)Founder, CEO & Director Compensation: $2.38MMs. Elizabeth L. Hougen M.A. (Age 62)M.B.A., M.S., Executive VP of Finance & CFO Compensation: $1.14MMs. B. Lynne Parshall Esq. (Age 70)J.D., Director Compensation: $90kDr. Richard S. Geary Ph.D. (Age 66)Executive VP & Chief Development Officer Compensation: $1.01MDr. Eric E. Swayze Ph.D. (Age 58)Executive Vice President of Research Compensation: $1.01MMr. Darren GonzalesChief Accounting Officer & Senior VPDr. C. Frank Bennett BSc (Age 67)Ph.D., Executive VP & Chief Scientific Officer Compensation: $651.64kMr. D. Wade Walke Ph.D.Senior Vice President of Investor RelationsMr. Patrick R. O'Neil Esq. (Age 50)Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary Compensation: $815.69kMs. Hayley SofferVice President of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies BIIB Insider Buying UTHR Insider Buying NBIX Insider Buying INCY Insider Buying BMRN Insider Buying EXAS Insider Buying EXEL Insider Buying RGEN Insider Buying MDGL Insider Buying HALO Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:IONS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
